Non classé

For partners: Want to showcase CCHFVACIM activities? Download our A0 poster! If you’re looking for a clear, visual way to communicate about the CCHFVACIM project, our A0 poster is the perfect tool. Whether you’re attending a conference, meeting with partners, or simply want to raise awareness, this poster gives a concise and impactful overview of…

(…)

Immunogenicity of NSDV GP38 and the Role of Furin in Glycoprotein Processing We are proud to highlight a new peer-reviewed publication by Kerstin Fischer and colleagues at the Friedrich-Loeffler-Institut (FLI), supported by the CCHFVacim project and funded by the European Health and Digital Executive Agency (HaDEA). 🔬 The study explores the presence and immunogenicity of the GP38 glycoprotein in sheep…

(…)

Why is it so important to develop medical counter measures against CCHF virus ? Listen to Ali Mirazimi’s answer in Thessaloniki (or read it: subtitled with Kapwing).

(…)

What an incredible meeting in Thessaloniki!It was a real pleasure seeing the fantastic progress of the CCHFVACIM project. A huge congratulations to the entire team! We’re excited to share that the data collected will be key to advancing a vaccine candidate to Phase I trials. Stay tuned for upcoming publications and further milestones—this is just…

(…)

On 2024, December 5, the CCHFVACIM Executive Committee convened in Brussels at the Residence Palace for a morning of strategic discussions and updates. This pivotal meeting brought project partners together to review progress, address challenges, and outline priorities for the months ahead. Agenda Highlights Key Takeaways and Priorities Expected Impact Funded by Horizon Europe, CCHFVACIM aims to enhance preparedness against the Crimean-Congo Hemorrhagic Fever…

(…)

Learn how our consortium is working to develop innovative mRNA vaccines and immunotherapies against Crimean-Congo Hemorrhagic Fever (CCHF). Download the Brochure

(…)